Published in Nature Communications · View the paper (DOI)
A new drug developed by UNM researchers enables surgeons to better see nerves during surgery, improving safety and efficiency. The Phase 3 trial is currently underway and aims to assess whether the imaging agent improves overall surgical outcomes.
Coverage from 2 institutions